首页> 外文期刊>Global health research and policy. >Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
【24h】

Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria

机译:尼日利亚北部中部洛科贾医疗保健提供者偏爱基于青蒿素的联合治疗

获取原文
           

摘要

Background In Nigeria, Artemisinin-based Combination Therapy (ACT) is the recommended first line antimalarial medicine for uncomplicated malaria. However, health care providers still continue the use of less efficacious?medicines such as Sulphadoxine-pyrimethamine and chloroquine. We therefore determined preference for ACT (PFA) and factors associated with PFA among healthcare providers (HCP) in Lokoja, North-Central Nigeria as well as assessed healthcare providers’ knowledge of malaria case management. Methods We conducted a cross-sectional study among physicians, nurses, pharmacists, community health officers (CHOs), community health extension workers (CHEWs) and, patent and proprietary medicine vendors (PPMVs). Interviewer-administered questionnaires were administered to collect data on respondents’ characteristics, previously received malaria case management training and knowledge of malaria treatment. Knowledge scores ≥3 were categorised as good, maximum obtainable being 5. Results Of the 404 respondents, 214 (53.0%) were males. Overall, 219 (54.2%) respondents who received malaria case management training included PPMVs: 79 (65.8%), CHEWs: 25 (64.1%), CHOs: 5 (55.6%), nurses: 72?(48.7%), physicians: 35 (47.3%) and pharmacists: 3 (23.1%). Overall, 202 (50.0%) providers including physicians: 69 (93.2%), CHO: 8 (88.9%), CHEWs: 33 (84.6%), pharmacists: 8 (61.5%), nurses: 64?(43.2%) and PPMVs: 20 (16.5%), had good knowledge of malaria treatment guidelines. Overall, preference for ACT among healthcare providers was 39.6%. Physicians: 50 (67.6%), pharmacists: 7 (59.3%) CHOs: 5 (55.6%), CHEWS: 16 (41.0%), nurses: 56 (37.8%) and PPMV: 24 (19.8%) had PFA. Receiving malaria case management training (adjusted odds ratio [aOR])?=?2.3; CI?=?1.4?–?3.7) and having good knowledge of malaria treatment (aOR?=?4.0; CI?=?2.4?–?6.7) were associated with PFA. Conclusions Overall preference for ACT use was low among health care providers in this study. Preference for ACTs and proportion of health workers with good knowledge of malaria case management were even lower among PPMVs who had highest proportion of those who received malaria case management training. We recommend evaluation of current training quality, enhanced targeted training, follow-up supportive supervision of PPMVs and behavior change communication on ACT use.
机译:背景技术在尼日利亚,基于青蒿素的联合疗法(ACT)是推荐的用于单纯性疟疾的一线抗疟药物。但是,医疗保健提供者仍继续使用疗效较差的药物,例如磺胺多辛-乙胺嘧啶和氯喹。因此,我们确定了尼日利亚北部中部洛科贾医疗保健提供者(HCP)对ACT(PFA)的偏好以及与PFA相关的因素,并评估了医疗保健提供者对疟疾病例管理的知识。方法我们在医师,护士,药剂师,社区卫生官员(CHOs),社区卫生推广人员(CHEW)以及专利和专有药品销售商(PPMV)之间进行了横断面研究。采访者管理的问卷被收集来​​收集有关受访者特征,先前接受过疟疾病例管理培训和疟疾治疗知识的数据。知识得分≥3被归类为好,最高得分为5。结果在404名受访者中,214名(53.0%)是男性。总体而言,接受疟疾病例管理培训的219位(54.2%)受访者包括PPMV:79(65.8%),CHEW:25(64.1%),CHOs:5(55.6%),护士:72?(48.7%),医生: 35(47.3%)和药剂师:3(23.1%)。总体而言,共有202(50.0%)位医疗服务提供者,其中包括医生:69(93.2%),CHO:8(88.9%),CHEWs:33(84.6%),药剂师:8(61.5%),护士:64?(43.2%)和PPMV:20(16.5%),对疟疾治疗指南有很好的了解。总体而言,医疗保健提供者对ACT的偏爱率为39.6%。内科医师:50(67.6%),药剂师:7(59.3%)CHOs:5(55.6%),CHEWS:16(41.0%),护士:56(37.8%)和PPMV:24(19.8%)有PFA。接受疟疾病例管理培训(调整后的优势比[aOR])?=?2.3; PFA与CI≥1.4?-?3.7)以及对疟疾治疗有良好的认识(aOR?=?4.0; CI?=?2.4?-?6.7)。结论在本研究中,卫生保健提供者对使用ACT的总体偏好较低。在接受过疟疾病例管理培训的比例最高的PPMV中,对ACTs的偏爱和对疟疾病例管理有充分了解的卫生工作者的比例甚至更低。我们建议评估当前的培训质量,加强有针对性的培训,PPMV的后续支持监督以及关于ACT使用的行为改变交流。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号